• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

养阴益气合剂通过抑制TGF-β1/Smad信号通路及上皮-间质转化改善博来霉素诱导的大鼠肺纤维化

Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition.

作者信息

Meng Lihong, Zhang Xiaomei, Wang Hong, Dong Huan, Gu Xiaofeng, Yu Xiaolin, Liu Yushan

机构信息

Beijing University of Chinese Medicine, No. 11 on North 3rd Ring Road, Beijing 100029, China.

Department of Respiratory Medicine, Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, No. 6 on 1st District of Fangxingyuan, Beijing 100078, China.

出版信息

Evid Based Complement Alternat Med. 2019 Jan 3;2019:2710509. doi: 10.1155/2019/2710509. eCollection 2019.

DOI:10.1155/2019/2710509
PMID:30719057
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6335662/
Abstract

OBJECTIVE

The aim of the current study was to investigate the protective effect of Yangyin Yiqi Mixture (YYYQ) on Bleomycin-induced pulmonary fibrosis in rats based on TGF-1/Smad signal pathway and epithelial to mesenchymal transition (EMT).

METHODS

120 Wistar rats were randomly divided into six groups: control group, BLM group, BLM + Pred group, BLM+YYYQ-L group, BLM+YYYQ-M group, and BLM+YYYQ-H group. Rats were given an intratracheal instillation of 3 mg/kg BLM to establish the pulmonary fibrosis model and followed by different dosages of YYYQ (11, 22, 44g/kg, via intragastric gavage) or prednisone soluble (4.2mg/kg, via intragastric gavage) or water. After 14 days and 28 days, tissue sections were stained with hematoxylin-eosin and Masson's trichrome to observe histopathological changes. Protein levels of TGF-1, CTGF, Interleukin 18, and hydroxyproline were detected by ELISA method, and mRNA expressions of TGF-1, TRI, TRII, Smad3, Smad7, -SMA, E-cadherin, laminin, and collagen I were detected by RT-PCR.

RESULTS

TGF-1, CTGF, Interleukin 18, and hydroxyproline levels and mRNA expression of TGF-1, TRI, TRII, Smad3, -SMA, laminin, and collagen I were significantly increased ( <0.01), while Smad7 and E-cadherin levels were significantly decreased in BLM group ( <0.01). YYYQ-M and YYYQ-H group had downregulated the TGF-1, CTGF, hydroxyproline contents, and mRNA expression of TGF-1, TRI, TRII, Smad3, -SMA, laminin, and collagen I and upregulated mRNA levels of Smad7 and E-cadherin significantly ( <0.01 or <0.05). The result from the present study, which was also supported by histological evidence, suggested that YYYQ-M group and YYYQ-H group exhibited better treatment effect on Bleomycin-induced pulmonary fibrotic rats when compared to that of BLM + Pred group ( <0.01). Meanwhile, the effect of YYYQ, in three different dosages, on the level of interleukin 18 was not significant.

CONCLUSION

These results showed that YYYQ has the potential of ameliorating the progression of pulmonary fibrosis, and the mechanism may be related to suppressing TGF-1/Smad signal pathway and EMT in BLM-induced pulmonary fibrosis of rats.

摘要

目的

本研究旨在基于转化生长因子 -1(TGF -1)/Smad信号通路和上皮 - 间充质转化(EMT),探讨养阴益气合剂(YYYQ)对博来霉素诱导的大鼠肺纤维化的保护作用。

方法

将120只Wistar大鼠随机分为六组:对照组、博来霉素(BLM)组、BLM + 泼尼松(Pred)组、BLM+YYYQ - 低剂量(L)组、BLM+YYYQ - 中剂量(M)组和BLM+YYYQ - 高剂量(H)组。通过气管内滴注3mg/kg博来霉素建立肺纤维化模型,随后分别给予不同剂量的YYYQ(11、22、44g/kg,灌胃)或泼尼松龙(4.2mg/kg,灌胃)或水。14天和28天后,取组织切片进行苏木精 - 伊红染色和Masson三色染色,观察组织病理学变化。采用酶联免疫吸附测定(ELISA)法检测TGF -1、结缔组织生长因子(CTGF)、白细胞介素18和羟脯氨酸的蛋白水平,采用逆转录 - 聚合酶链反应(RT - PCR)法检测TGF -1、I型转化生长因子受体(TRI)、II型转化生长因子受体(TRII)、Smad3、Smad7、α - 平滑肌肌动蛋白(α - SMA)、E - 钙黏蛋白、层粘连蛋白和I型胶原蛋白的mRNA表达。

结果

BLM组中,TGF -1、CTGF、白细胞介素18和羟脯氨酸水平以及TGF -1、TRI、TRII、Smad3、α - SMA、层粘连蛋白和I型胶原蛋白的mRNA表达显著升高(P <0.01),而Smad7和E - 钙黏蛋白水平显著降低(P <0.01)。YYYQ - M组和YYYQ - H组显著下调了TGF -1、CTGF、羟脯氨酸含量以及TGF -1、TRI、TRII、Smad3、α - SMA、层粘连蛋白和I型胶原蛋白的mRNA表达,并显著上调了Smad7和E - 钙黏蛋白的mRNA水平(P <0.01或P <0.05)。本研究结果也得到组织学证据的支持,表明与BLM + Pred组相比,YYYQ - M组和YYYQ - H组对博来霉素诱导的肺纤维化大鼠表现出更好的治疗效果(P <0.01)。同时,三种不同剂量的YYYQ对白细胞介素18水平的影响不显著。

结论

这些结果表明,YYYQ具有改善肺纤维化进展的潜力,其机制可能与抑制TGF -1/Smad信号通路和大鼠博来霉素诱导的肺纤维化中的EMT有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/6335662/06d267bc3595/ECAM2019-2710509.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/6335662/00f9fcf25e1d/ECAM2019-2710509.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/6335662/755dc23caf7f/ECAM2019-2710509.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/6335662/b43c092e984b/ECAM2019-2710509.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/6335662/8ee690ae169c/ECAM2019-2710509.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/6335662/ef679df31492/ECAM2019-2710509.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/6335662/ad942f1b1532/ECAM2019-2710509.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/6335662/06d267bc3595/ECAM2019-2710509.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/6335662/00f9fcf25e1d/ECAM2019-2710509.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/6335662/755dc23caf7f/ECAM2019-2710509.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/6335662/b43c092e984b/ECAM2019-2710509.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/6335662/8ee690ae169c/ECAM2019-2710509.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/6335662/ef679df31492/ECAM2019-2710509.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/6335662/ad942f1b1532/ECAM2019-2710509.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/6335662/06d267bc3595/ECAM2019-2710509.007.jpg

相似文献

1
Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition.养阴益气合剂通过抑制TGF-β1/Smad信号通路及上皮-间质转化改善博来霉素诱导的大鼠肺纤维化
Evid Based Complement Alternat Med. 2019 Jan 3;2019:2710509. doi: 10.1155/2019/2710509. eCollection 2019.
2
Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.氢气吸入通过抑制转化生长因子-β1 及相关氧化应激和上皮间质转化来减轻博来霉素诱导的肺纤维化。
Exp Physiol. 2019 Dec;104(12):1942-1951. doi: 10.1113/EP088028. Epub 2019 Oct 23.
3
GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition.甘氨酰-L-组氨酰-L-赖氨酸三肽通过抑制转化生长因子β1/ Smad介导的上皮-间质转化抑制博来霉素诱导的小鼠肺纤维化。
Front Pharmacol. 2017 Dec 12;8:904. doi: 10.3389/fphar.2017.00904. eCollection 2017.
4
Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.萝卜硫素通过抑制上皮-间质转化减轻肺纤维化。
BMC Pharmacol Toxicol. 2018 Apr 2;19(1):13. doi: 10.1186/s40360-018-0204-7.
5
[Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].[穿心莲内酯对博莱霉素诱导的大鼠肺纤维化模型中支气管肺泡灌洗液(BALF)中细胞因子浓度及肺组织中Ⅰ型和Ⅲ型胶原mRNA表达的影响]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011 Jul;27(7):725-9.
6
[Anti-fibrotic effects of angiotensin1-7 on bleomycin-induced pulmonary fibrosis in rats].血管紧张素1-7对博莱霉素诱导的大鼠肺纤维化的抗纤维化作用
Zhonghua Yi Xue Za Zhi. 2013 May 28;93(20):1585-9.
7
All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-β1/Smad3 signaling pathway in rats.全反式维甲酸通过下调 TGF-β1/Smad3 信号通路改善博来霉素诱导的大鼠肺纤维化。
Lab Invest. 2013 Nov;93(11):1219-31. doi: 10.1038/labinvest.2013.108. Epub 2013 Sep 16.
8
[Effects of Notch-1/Twist-1 axis in the process of epithelial-mesenchymal transition of type II alveolar epithelial cell and its mechanism].Notch-1/Twist-1轴在Ⅱ型肺泡上皮细胞上皮-间质转化过程中的作用及其机制
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2021 Nov;37(6):577-583. doi: 10.12047/j.cjap.6124.2021.048.
9
Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.可溶性环氧化物水解酶抑制剂AUDA通过抑制p38/Smad3信号通路减轻博来霉素诱导的小鼠肺毒性。
Toxicology. 2017 Aug 15;389:31-41. doi: 10.1016/j.tox.2017.07.002. Epub 2017 Jul 8.
10
Danggui Buxue Tang ameliorates bleomycin-induced pulmonary fibrosis in rats through inhibiting transforming growth factor-β1/Smad3/ plasminogen activator inhibitor-1 signaling pathway.当归补血汤通过抑制转化生长因子-β1/ Smad3/纤溶酶原激活物抑制剂-1信号通路改善博来霉素诱导的大鼠肺纤维化。
J Tradit Chin Med. 2020 Apr;40(2):236-244.

引用本文的文献

1
Echinacea purpurea ameliorates Bleomycin-induced pulmonary fibrosis in rats through modulating NADPH oxidase-4 and endothelin-1/connective tissue growth factor/matrix metalloproteinases signalling axis.紫锥菊通过调节NADPH氧化酶-4和内皮素-1/结缔组织生长因子/基质金属蛋白酶信号轴改善博来霉素诱导的大鼠肺纤维化。
Sci Rep. 2025 Sep 2;15(1):32332. doi: 10.1038/s41598-025-06559-9.
2
Green synthesis, characterization, anti-SARS-CoV-2 entry, and replication of lactoferrin-coated zinc nanoparticles with halting lung fibrosis induced in adult male albino rats.乳铁蛋白包覆的氧化锌纳米粒子的绿色合成、特性分析、抗 SARS-CoV-2 进入与复制,及其对雄性成年白化大鼠肺部纤维化的抑制作用。
Sci Rep. 2023 Sep 23;13(1):15921. doi: 10.1038/s41598-023-42702-0.
3

本文引用的文献

1
Combination of and ligustrazine attenuates bleomycin-induced pulmonary fibrosis in rats via modulating TNF-α and TGF-β.[具体物质名称]与川芎嗪联合通过调节肿瘤坏死因子-α和转化生长因子-β减轻博来霉素诱导的大鼠肺纤维化。 (原文中“Combination of and ligustrazine”部分有缺失内容)
Chin Med. 2018 Jul 4;13:36. doi: 10.1186/s13020-018-0194-9. eCollection 2018.
2
Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.萝卜硫素通过抑制上皮-间质转化减轻肺纤维化。
BMC Pharmacol Toxicol. 2018 Apr 2;19(1):13. doi: 10.1186/s40360-018-0204-7.
3
2-aminopurine suppresses the TGF-β1-induced epithelial-mesenchymal transition and attenuates bleomycin-induced pulmonary fibrosis.
Ameliorative Potential of Donepezil with or without Prednisolone in Bleomycin-Induced Pulmonary Fibrosis in Rats: Involvement of the Anti-Inflammatory, Antioxidant, and the Antifibrotic Pathways.
多奈哌齐联合泼尼松龙对博来霉素诱导的大鼠肺纤维化的改善作用:抗炎、抗氧化和抗纤维化途径的参与。
Medicina (Kaunas). 2023 May 19;59(5):980. doi: 10.3390/medicina59050980.
4
From Basic Research to Clinical Practice: Considerations for Treatment Drugs for Silicosis.从基础研究到临床实践:矽肺治疗药物的考虑因素。
Int J Mol Sci. 2023 May 5;24(9):8333. doi: 10.3390/ijms24098333.
5
Jinlian Xiaodu Decoction Protects against Bleomycin-Induced Pulmonary Fibrosis in Rats.金莲消毒饮对博莱霉素诱导的大鼠肺纤维化具有保护作用。
Evid Based Complement Alternat Med. 2022 Jun 23;2022:4206364. doi: 10.1155/2022/4206364. eCollection 2022.
6
Scorpion Venom Polypeptide Inhibits Pulmonary Epithelial-Mesenchymal Transition in Systemic Sclerosis-Interstitial Lung Disease Model Mice by Intervening TGF-1/Smad Signaling Pathway.蝎毒多肽通过干预TGF-β1/Smad信号通路抑制系统性硬化症-间质性肺病模型小鼠的肺上皮-间质转化
Evid Based Complement Alternat Med. 2022 Apr 13;2022:6557486. doi: 10.1155/2022/6557486. eCollection 2022.
7
Epithelial-mesenchymal transition in organ fibrosis development: current understanding and treatment strategies.器官纤维化发展中的上皮-间质转化:当前认识与治疗策略
Burns Trauma. 2022 Apr 8;10:tkac011. doi: 10.1093/burnst/tkac011. eCollection 2022.
8
Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis.天然产物治疗肺纤维化的潜在疗法。
Molecules. 2022 Feb 22;27(5):1481. doi: 10.3390/molecules27051481.
9
Role of nuclear factor-kappa B in bleomycin induced pulmonary fibrosis and the probable alleviating role of ginsenoside: histological, immunohistochemical, and biochemical study.核因子-κB在博来霉素诱导的肺纤维化中的作用及人参皂苷可能的缓解作用:组织学、免疫组织化学和生化研究
Anat Cell Biol. 2021 Dec 31;54(4):448-464. doi: 10.5115/acb.21.068.
10
MiR-200a inversely correlates with Hedgehog and TGF-β canonical/non-canonical trajectories to orchestrate the anti-fibrotic effect of Tadalafil in a bleomycin-induced pulmonary fibrosis model.miR-200a 与 Hedgehog 和 TGF-β 经典/非经典轨迹呈负相关,从而协调他达拉非在博来霉素诱导的肺纤维化模型中的抗纤维化作用。
Inflammopharmacology. 2021 Feb;29(1):167-182. doi: 10.1007/s10787-020-00748-w. Epub 2020 Sep 10.
2-氨基嘌呤可抑制转化生长因子-β1诱导的上皮-间质转化,并减轻博来霉素诱导的肺纤维化。
Cell Death Discov. 2018 Feb 13;4:17. doi: 10.1038/s41420-017-0016-3. eCollection 2018 Dec.
4
[Inhibitory effect of Glehniae Radix petroleum ether part on TGF-β1-induced epithelial mesenchymal transition in A549 cells].[北沙参石油醚部位对转化生长因子-β1诱导A549细胞上皮-间质转化的抑制作用]
Zhongguo Zhong Yao Za Zhi. 2017 May;42(9):1736-1741. doi: 10.19540/j.cnki.cjcmm.20170222.008.
5
Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.特发性肺纤维化的新兴疗法,一种与年龄相关的进行性疾病。
Nat Rev Drug Discov. 2017 Nov;16(11):755-772. doi: 10.1038/nrd.2017.170. Epub 2017 Oct 6.
6
Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-β1 mediated Smad2/3 and ERK1/2 activation.白细胞介素-17通过转化生长因子-β1介导的Smad2/3和ERK1/2激活诱导人肺泡上皮细胞向间充质细胞转化。
PLoS One. 2017 Sep 5;12(9):e0183972. doi: 10.1371/journal.pone.0183972. eCollection 2017.
7
Association of serum levels of laminin, type IV collagen, procollagen III N-terminal peptide, and hyaluronic acid with the progression of interstitial lung disease.层粘连蛋白、IV型胶原、III型前胶原N端肽和透明质酸血清水平与间质性肺疾病进展的关联。
Medicine (Baltimore). 2017 May;96(18):e6617. doi: 10.1097/MD.0000000000006617.
8
Antifibrotic effects of cyclosporine A on TGF-β1-treated lung fibroblasts and lungs from bleomycin-treated mice: role of hypoxia-inducible factor-1α.环孢素A对转化生长因子-β1处理的肺成纤维细胞及博来霉素处理小鼠肺组织的抗纤维化作用:缺氧诱导因子-1α的作用
FASEB J. 2017 Aug;31(8):3359-3371. doi: 10.1096/fj.201601357R. Epub 2017 Apr 26.
9
Gastroesophageal Reflux and Idiopathic Pulmonary Fibrosis.胃食管反流与特发性肺纤维化
World J Surg. 2017 Jul;41(7):1691-1697. doi: 10.1007/s00268-017-3956-0.
10
HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.HYDAMTIQ是一种选择性PARP - 1抑制剂,通过抑制TGF - β/SMAD信号通路来改善博来霉素诱导的肺纤维化。
J Cell Mol Med. 2017 Feb;21(2):324-335. doi: 10.1111/jcmm.12967. Epub 2016 Oct 4.